Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Cyclacel Pharmaceuticals Inc.
DescriptionCyclin dependent kinase 2 (CDK2) and CDK9 inhibitor
Molecular Target Cyclin dependent kinase 2 (CDK2) ; Cyclin dependent kinase 9 (CDK9)
Mechanism of ActionCyclin dependent kinase (CDK) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationNeuroendocrine tumors
Indication DetailsTreat neuroblastoma
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today